SUSMED, Inc. (headquartered in Chuo-ku, Tokyo; President and Representative Director: Taro Ueno; hereinafter, “SUSMED”), a company in which Beyond Next Ventures Inc. has invested as a lead investor since 2016, was listed on the Mothers Market of the Tokyo Stock Exchange on December 24, 2021.

With the aim of realizing “Sustainable Medicine,” as reflected in its name, SUSMED develops its own therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. The company also provides the “SUSMED System,” which utilizes proprietary blockchain technology to promote greater efficiency in clinical trials.

SUSMED website: https://susmed.co.jp/